Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

od DeRemer, David L, Katsanevas, Katerina, Ustun, Celalettin
Izdano 2011

Anti-angiogenic therapy for cancer: An update

od Al-Husein, Belal, Abdalla, Maha, Trepte, Morgan, DeRemer, David L., Somanath, Payaningal R.
Izdano 2012

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

od Goc, Anna, Al-Husein, Belal, Katsanevas, Katerina, Steinbach, Alison, Lou, Uvette, Sabbineni, Harika, DeRemer, David L., Somanath, Payaningal R.
Izdano 2014

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists’ Patient Care Process

od Phillips, Beth Bryles, Newsome, Andrea Sikora, Bland, Christopher M., Palmer, Russ, Smith, Katie, DeRemer, David L., Phan, Stephanie V.
Izdano u Am J Pharm Educ (2019)

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center

od Waheed, Nida, Fradley, Michael G., DeRemer, David L., Mahmoud, Ahmad, Shah, Chintan P., Langaee, Taimour Y., Lipori, Gloria P., March, Keith, Pepine, Carl J., Cooper-DeHoff, Rhonda M., Wu, Yonghui, Gong, Yan
Izdano u Cardiooncology (2021)

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis

od Tantawy, Marwa, Chekka, Lakshmi Manasa, Huang, Yimei, Garrett, Timothy J., Singh, Sonal, Shah, Chintan P., Cornell, Robert F., Baz, Rachid C., Fradley, Michael G., Waheed, Nida, DeRemer, David L., Yuan, Lihui, Langaee, Taimour, March, Keith, Pepine, Carl J., Moreb, Jan S., Gong, Yan
Izdano u Front Cardiovasc Med (2021)